| Freestyle Libre 3 Wear Time | 14 days |
| Dexcom G7 Wear Time | 10 days |
| Reading Frequency | Every 1β5 minutes |
| Calibration Required | None (leading 2026 models) |
| Target Time-in-Range | 70β180 mg/dL, >70% of day |
| ADA Recommendation | CGM for all insulin-treated Type 2 |
Key Takeaways
- CGM is now recommended for many Type 2 diabetics, not just Type 1
- Real-time glucose data helps reduce HbA1c and prevent hypoglycemia
- Affordable options exist for non-insulin users in 2026
- MDS Diabetes stocks leading CGM sensors with fast delivery
What Is a CGM?
A Continuous Glucose Monitor (CGM) is a wearable sensor β typically placed on the arm or abdomen β that measures interstitial glucose every 1β5 minutes. Unlike fingerstick tests, CGMs reveal glucose trends, spikes, and overnight patterns that traditional monitoring misses entirely.
Do Type 2 Diabetics Need a CGM in 2026?
Clinical guidelines have shifted significantly. The American Diabetes Association (ADA) 2025β2026 Standards of Care now recommend CGM consideration for any person with Type 2 diabetes on insulin, and strongly suggest it for those experiencing hypoglycemia unawareness or persistent HbA1c above target.
Even for non-insulin Type 2 users, evidence shows CGM drives meaningful behaviour change β reducing post-meal spikes through dietary awareness alone.
Who Benefits Most?
- Insulin-treated Type 2: Essential for dosing accuracy and safety
- High HbA1c (>8%): Identifies hidden glucose patterns
- Hypoglycemia unawareness: Alerts prevent dangerous lows
- Diet-focused management: Real-time feedback on food choices
- Newly diagnosed: Accelerates learning and engagement
Top CGM Sensors for Type 2 Diabetes (2026)
| Device | Wear Time | Calibration | Alerts | Best For |
|---|---|---|---|---|
| Freestyle Libre 3 | 14 days | None required | Yes | Everyday use, non-insulin |
| Dexcom G7 | 10 days | None required | Yes | Insulin users, pump integration |
| Medtronic Simplera | 14 days | None required | Yes | Medtronic pump users |
| Libre 2 Plus | 15 days | None required | Real-time | Budget-conscious users |
CGM vs Fingerstick Testing
Traditional blood glucose monitoring (BGM) provides a single snapshot. CGM delivers up to 288 readings per day, revealing the full glucose curve. Studies show CGM users spend significantly more time-in-range (TIR) β the gold-standard metric for 2026 diabetes management β compared to fingerstick-only users.
Cost and Accessibility in 2026
CGM costs have dropped substantially. Entry-level sensors like the Freestyle Libre 2 are available without prescription in many countries. NHS coverage in the UK has expanded to include Type 2 patients on insulin. Private purchase remains straightforward β MDS Diabetes offers competitive pricing on all major CGM sensors with next-day delivery options.
Practical Tips for Getting Started
- Start with a 14-day trial sensor to assess your glucose patterns
- Use the companion app to identify your personal high-spike foods
- Share CGM data with your diabetes care team at each appointment
- Combine CGM data with Time-in-Range goals (target: 70β180 mg/dL for >70% of day)